Software by Light IT Global to facilitate next-gen sequencing analysis studies

While complex genetic changes drive 73% of all cancers, they remained unaddressed for a very long time. This had a negative impact on the development and quality of the cancer genomic software market and on the outcome of the studies as well.

Our client created a health tech startup to fill up the existing technological gap and provide scientists and researchers with highly precise and reliable next-generation sequencing analysis. And while a modern cancer genomic software market is worth EUR 2.8 billion, the European IT market didn’t really have much competition in this niche.

That’s why Light IT Global was trusted to create a digital platform that would safeguard optimal turnaround time and help the health tech startup organize the workflow in the most efficient and convenient way.

Since the platform’s creation implies working with sensitive scientific data, the system’s integrity and fail-safeness were at the top of the priority list for this project. Every solution’s element was thoroughly tested, and the incorporation of DevOps practices helped to improve the delivery speed as well as overall software quality.

To develop a platform for this health tech startup, Light IT Global’s experts have used a combination of the most reliable and versatile technology like Python, Django, PostgreSQL, Redis, and Uwsgi for back-end and Angular for front-end. This helped to secure the solution’s scalability, optimal performance, and stability. And while the dev and QA teams took care of the technical aspect of the project’s implementation, the design team created a modern design concept that would represent the brand in a professional yet appealing manner.

One of the system’s main goals is to unite professionals and promote knowledge sharing that would further assist the progress of gene editing studies. Therefore, we had to create a user-role-based access system where the functionality available to a specific person would be determined by their role.

Types of users that were expected to join the platform are:

Upon the completion of the registration and login process, each type of user is able to interact with the system via a dashboard. The core of the solution is ordering and consultation functionality. More specifically, the following:

All of the events within the system that may require the user’s attention (e.g., new meeting scheduled, order status change, checkout process completion, etc.) are backed up by email notifications and further improve the quality of the interaction with the platform.

As a result, the solution combines execution excellence with ease-of-use and overall coherence, which positively impacts the customers’ experience and brand loyalty.

A comprehensive and fully compliant healthcare solution developed by Light IT Global helped our client’s health tech startup become more visible on the market and monetize their expertise in next-generation sequencing for gene editing. The platform allows the researchers to not only buy necessary products and services but also to receive consultations from experts that meet specific strict criteria and do it all on a budget.

The system helps our client analyze large volumes of data quickly yet thoroughly and keep the sample-to-analysis turnaround time minimized. Proprietary sequencing algorithms facilitate primary and secondary analysis, which is followed by results interpretation and validation.

Consequently, researchers, being the target audience of the platform, get access to services related to the Nobel-prize-awarded CRISPR-Cas9 method and have an opportunity to improve the accuracy of their experiments.

By providing research groups with a reliable tool that allows them to get ultra-precise in-depth analysis results and information beyond the capacity of traditional DNA sequencing technology, our client helps to minimize the time between scientific discovery and its real-life application.

With software solutions like this, researchers around the world will have better access to the expertise and necessary instruments to advance their work and promote global scientific and technological progress.

And while this specific solution has a relatively limited target audience (experts working in biological sciences), it is still sought-after and easily monetized due to its innovative nature. Moreover, the range of products offered by our client’s company can be expanded in the future, which will boost the profitability.